Back to Search
THERESA HUGHES, MD
MD
Internal Medicine Physician
NPI: 1417036047IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
2000161125(MO)
Education
UNIVERSITY OF MISSOURI, COLUMBIA SCHOOL OF MEDICINE
Class of 1997
Research & Publications (20)
Clinical strategies to achieve an early and successful response to tyrosine kinase inhibitor therapy.
PMID 19621544·Semin Hematol·2009
8-other
Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phase.
PMID 19652056·J Clin Oncol·2009
3-trial
Immunogenicity of intrathecal plasmid gene delivery: cytokine release and effects on transgene expression.
PMID 19533588·J Gene Med·2009
7-preclinical
Intrathecal injection of naked plasmid DNA provides long-term expression of secreted proteins.
PMID 18941439·Mol Ther·2009
7-preclinical
Is drug treatment superior to allografting as first-line therapy in chronic myeloid leukemia?
PMID 17940526·Nat Clin Pract Oncol·2008
8-other
Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy.
PMID 18768781·Blood·2008
3-trial
First records of Aedes japonicus japonicus in Wisconsin.
PMID 19181068·J Am Mosq Control Assoc·2008
7-preclinical
Prediction and testing of novel transcriptional networks regulating embryonic stem cell self-renewal and commitment.
PMID 18371337·Cell Stem Cell·2007
8-other
Regions of alpha-amino-5-methyl-3-hydroxy-4-isoxazole propionic acid receptor subunits that are permissive for the insertion of green fluorescent protein.
PMID 16765522·Neuroscience·2006
4-observational
ABL kinase inhibitor therapy for CML: baseline assessments and response monitoring.
PMID 17124063·Hematology Am Soc Hematol Educ Program·2006
6-review
Regulation of gene expression by alternative untranslated regions.
PMID 16430990·Trends Genet·2006
6-review
Molecular monitoring of BCR-ABL as a guide to clinical management in chronic myeloid leukaemia.
PMID 16426942·Blood Rev·2006
6-review
Regulation of axin2 expression at the levels of transcription, translation and protein stability in lung and colon cancer.
PMID 15885887·Cancer Lett·2006
8-other
E2F1 up-regulates the expression of the tumour suppressor axin2 both by activation of transcription and by mRNA stabilisation.
PMID 15766563·Biochem Biophys Res Commun·2005
8-other
Expression of axin2 is regulated by the alternative 5'-untranslated regions of its mRNA.
PMID 15611123·J Biol Chem·2005
8-other
Cross-talk between pRb/E2F and Wnt/beta-catenin pathways: E2F1 induces axin2 leading to repression of Wnt signalling and to increased cell death.
PMID 15572025·Exp Cell Res·2005
7-preclinical
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia.
PMID 14534335·N Engl J Med·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 621 S NEW BALLAS RD, SUITE 3016B
SAINT LOUIS, MO 63141 - Phone
- (314) 251-6339
Quick Facts
- NPI
- 1417036047
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 29
- Publications
- 20
Are you this provider?
Claim Your Profile